PrimeRFP
PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40123F19029CBER DSAC FIRM FIXED PRICE AWARD — Translation Excellence Inc

Translation Excellence Inc holds $19.7M across 102 federal awards, concentrated at Department of the Treasury (TREAS). This PIID sits alongside 5 related awards under parent 75F40118D10055. The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jun 16, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
Translation Excellence Inc
Recipient
Jun 16, 2026
PoP end
$11M
Obligated
$8.6M
Potential
541930
NAICS
R608
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Translation Excellence Inc — $90

Contract facts

Federal
Contract number75F40123F19029
Also listed as75F40118D10055-75F40123F19029
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentTranslation Excellence Inc
CAGE68UD1
UEILSEHC45NMB28
NAICS541930

No full NAICS 541930 intel page yet. Browse NAICS intelligence

PSCR608
Parent IDIQ / IDV75F40118D10055
Place of performanceROCKVILLE MD
Pricing typeFirm Fixed Price
Extent competedNot Competed Under SAP
PoP startDec 13, 2022
PoP end (current)Jun 16, 2026
PoP end (w/ options)Jun 17, 2026
Obligated$11M
Current value$11M
Potential value$8.6M

FIRM FIXED PRICE AWARD CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) - DIVISION OF SCIENTIFIC ADVISORS AND CONSULTANTS (DSAC) - DIVISION OF SCIENTIFIC ADVISORS AND CONSULTANTS (DSAC) TRANSCRIPTION SERVICES COR: CHRISTINA VERT CHRISTINA.VERT@F is a federal award for Fda Office Of Acq Grant Svcs held by Translation Excellence Inc. Estimated value $8.6M ($11M obligated). Current period of performance ends Jun 16, 2026 (potential Jun 17, 2026). Last award drew 1 bidder. Place of performance: ROCKVILLE MD.

FIRM FIXED PRICE AWARD CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) - DIVISION OF SCIENTIFIC ADVISORS AND CONSULTANTS (DSAC) - DIVISION OF SCIENTIFIC ADVISORS AND CONSULTANTS (DSAC) TRANSCRIPTION SERVICES COR: CHRISTINA VERT CHRISTINA.VERT@F

Recompete timing

Public
● Past PoP end (86 days ago)

Current PoP ended Jun 16, 2026 (86 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Translation Excellence Inc — $19.7M obligated across 102 awards (firm-wide, all agencies) · lead buyer Department of the Treasury (TREAS).

% of firm-wide obligated ($19.7M) · all agencies · Top 4 shown (85%); remaining ~15% is other agencies.
Department of the Treasury (TREAS)$8.9M · 45%
Nuclear Regulatory Commission (NRC)$3.3M · 17%
National Aeronautics and Space Administration (NASA)$2.3M · 12%Department of Homeland Security (DHS)$2.3M · 12%
Open full company profile →

Related awards

Same parent · incumbent
75F40122F19022
LANGUAGE ACCESS SERVICES
$26.8M
Sep 11, 2026
75D30121C11095
FOREIGN LANGUAGE COACHING, TRANSLATION, & INTERPRETATION SERVICES
$2.0M
Sep 21, 2026
31310026C0009
SIGN LANGUAGE INTERPRETATION AND TRANSCRIPTION SERVICES
$489K
Oct 19, 2026
15JPSS26F00000806
TRANSCRIPTION SERVICES FOR THE MONTH OF FEBRUARY 2026.
$5.0M
Jun 30, 2027
80NSSC25FA437
CALL ORDER 8 ON BPA 80NSSC22AA012 FOR SIGN LANGUAGE INTERPRETERS.
$503K
Sep 8, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40123F19029?

75F40123F19029 (CBER DSAC FIRM FIXED PRICE AWARD) is a Fda Office Of Acq Grant Svcs award with a potential value of $8.6M, currently held by Translation Excellence Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40123F19029?

Fda Office Of Acq Grant Svcs awarded 75F40123F19029 to Translation Excellence Inc (potential $8.6M).

Who is the incumbent on 75F40123F19029?

Translation Excellence Inc is the incumbent with $19.7M across 102 related awards in SCOUT’s public footprint. The current period of performance ends Jun 16, 2026.

When does Translation Excellence Inc’s 75F40123F19029 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 16, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75F40123F19029 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40123F19029